Movesan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Movesan, is a glucocorticoid presented as a topical formulation for cutaneous use. It reduces inflammation and immune responses in various dermatologic conditions, and is prescribed for adults and children when a potent anti‑inflammatory agent is required.

GNH USA supplies Movesan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand, with a distribution network that ensures reliable delivery across Europe, Asia, Africa and the Americas.

Mometasone furoate topical is indicated for inflammatory skin disorders where corticosteroid therapy is appropriate. - Psoriasis: reduces plaque thickness and erythema, improving skin appearance. - Atopic dermatitis (eczema): alleviates itching and inflammation, promoting lesion healing. - Contact dermatitis: diminishes allergic skin reactions and redness. - Seborrheic dermatitis: controls flaking and scaling on scalp and face.

Topical application of mometasone furoate may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Skin dryness or peeling. - Erythema or mild redness. - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Secondary infection of the treated area. - Systemic cortisol suppression (rare). - Allergic contact dermatitis to the formulation.

When using Movesan, several safety considerations should be observed to minimize risks. - Avoid use on broken or infected skin: may increase systemic absorption. - Limit duration of treatment: use the lowest effective potency for the shortest time. - Apply thin layer only: excessive amounts raise risk of side effects. - Do not use occlusive dressings unless directed: can enhance drug penetration. - Consult a physician before use in pregnancy or lactation: safety data are limited. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone furoate may interact with other agents that affect corticosteroid activity or skin absorption.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels and side‑effect potential. - Immunosuppressive biologics: heightened risk of skin infections.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topical agents: may alter skin barrier and affect absorption. - Skin irritants or harsh cleansers: can increase irritation when combined. - Phototherapy (UVB): may enhance skin thinning if used together.